MicroRNAs regulate vascular medial calcification

Cells

Volumn 3, Issue 4, 2014, Pages 963-980

  Leopold, Jane A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Matrix vesicles; MicroRNAs; Osteoclasts; Vascular calcification; Vascular smooth muscle cells

Indexed keywords

MICRORNA;

BIOLOGY; BLOOD VESSEL CALCIFICATION; BONE MATRIX; BONE MINERALIZATION; CALCIUM HOMEOSTASIS; CELL TRANSDIFFERENTIATION; DOWN REGULATION; HUMAN; MONOCYTE; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOCLASTOGENESIS; PHENOTYPE; PHOSPHATE METABOLISM; REVIEW; VASCULAR SMOOTH MUSCLE;

EID: 84928650382     PISSN: None     EISSN: 20734409     Source Type: Journal    
DOI: 10.3390/cells3040963     Document Type: Review

References (87)

1. Bild, D.E.; Detrano, R.; Peterson, D.; Guerci, A.; Liu, K.; Shahar, E.; Ouyang, P.; Jackson, S.; Saad, M.F. Ethnic differences in coronary calcification: The multi-ethnic study of atherosclerosis (MESA). Circulation 2005, 111, 1313-1320.
2. Wong, N.D.; Kouwabunpat, D.; Vo, A.N.; Detrano, R.C.; Eisenberg, H.; Goel, M.; Tobis, J.M. Coronary calcium and atherosclerosis by ultrafast computed tomography in asymptomatic men and women: Relation to age and risk factors. Am. Heart J. 1994, 127, 422-430.
3. Rennenberg, R.J.; Kessels, A.G.; Schurgers, L.J.; van Engelshoven, J.M.; de Leeuw, P.W.; Kroon, A.A. Vascular calcifications as a marker of increased cardiovascular risk: A meta-analysis. Vasc. Health Risk Manag. 2009, 5, 185-197.
4. Detrano, R.; Guerci, A.D.; Carr, J.J.; Bild, D.E.; Burke, G.; Folsom, A.R.; Liu, K.; Shea, S.; Szklo, M.; Bluemke, D.A.; et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. New Engl. J. Med. 2008, 358, 1336-1345.
5. Polonsky, T.S.; Greenland, P. Coronary artery calcium scores using nongated computed tomography: What to do with incidental results? Circ. Cardiovasc. Imag. 2013, 6, 494-495.
6. Yeboah, J.; McClelland, R.L.; Polonsky, T.S.; Burke, G.L.; Sibley, C.T.; O’Leary, D.; Carr, J.J.; Goff, D.C.; Greenland, P.; Herrington, D.M. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA 2012, 308, 788-795.
7. Polonsky, T.S.; McClelland, R.L.; Jorgensen, N.W.; Bild, D.E.; Burke, G.L.; Guerci, A.D.; Greenland, P. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA 2010, 303, 1610-1616.
8. Greenland, P.; Bonow, R.O.; Brundage, B.H.; Budoff, M.J.; Eisenberg, M.J.; Grundy, S.M.; Lauer, M.S.; Post, W.S.; Raggi, P.; Redberg, R.F.; et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: A report of the American College of Cardiology Foundation clinical expert consensus task force. Circulation 2007, 115, 402-426.
9. Ghadri, J.R.; Fiechter, M.; Fuchs, T.A.; Scherrer, A.; Stehli, J.; Gebhard, C.; Klaser, B.; Gaemperli, O.; Luscher, T.F.; Templin, C.; et al. Registry for the evaluation of the prognostic value of a novel integrated imaging approach combining single photon emission computed tomography with coronary calcification imaging (REPROSPECT). Eur. Heart J. Cardiovasc. Imag. 2013, 14, 374-380.
10. Schenker, M.P.; Dorbala, S.; Hong, E.C.; Rybicki, F.J.; Hachamovitch, R.; Kwong, R.Y.; di Carli, M.F. Interrelation of coronary calcification, myocardial ischemia, and outcomes in patients with intermediate likelihood of coronary artery disease: A combined positron emission tomography/computed tomography study. Circulation 2008, 117, 1693-1700.
11. Fitzpatrick, L.A.; Severson, A.; Edwards, W.D.; Ingram, R.T. Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis. J. Clin. Invest. 1994, 94, 1597-1604.
12. Shanahan, C.M.; Cary, N.R.; Salisbury, J.R.; Proudfoot, D.; Weissberg, P.L.; Edmonds, M.E. Medial localization of mineralization-regulating proteins in association with monckeberg’s sclerosis: Evidence for smooth muscle cell-mediated vascular calcification. Circulation 1999, 100, 2168-2176.
13. Demer, L.L.; Tintut, Y. Inflammatory, metabolic, and genetic mechanisms of vascular calcification. Arterioscler. Thromb. Vasc. Biol. 2014, 34, 715-723.
14. Johnson, R.C.; Leopold, J.A.; Loscalzo, J. Vascular calcification: Pathobiological mechanisms and clinical implications. Circ. Res. 2006, 99, 1044-1059.
15. Bostrom, K.I.; Rajamannan, N.M.; Towler, D.A. The regulation of valvular and vascular sclerosis by osteogenic morphogens. Circ. Res. 2011, 109, 564-577.
16. Faverman, L.; Mikhaylova, L.; Malmquist, J.; Nurminskaya, M. Extracellular transglutaminase 2 activates beta-catenin signaling in calcifying vascular smooth muscle cells. FEBS Lett. 2008, 582, 1552-1557.
17. Reynolds, J.L.; Joannides, A.J.; Skepper, J.N.; McNair, R.; Schurgers, L.J.; Proudfoot, D.; Jahnen-Dechent, W.; Weissberg, P.L.; Shanahan, C.M. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: A potential mechanism for accelerated vascular calcification in esrd. J. Am. Soc. Nephrol. 2004, 15, 2857-2867.
18. Komori, T.; Yagi, H.; Nomura, S.; Yamaguchi, A.; Sasaki, K.; Deguchi, K.; Shimizu, Y.; Bronson, R.T.; Gao, Y.H.; Inada, M.; et al. Targeted disruption of cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997, 89, 755-764.
19. Lian, J.B.; Stein, G.S.; Javed, A.; van Wijnen, A.J.; Stein, J.L.; Montecino, M.; Hassan, M.Q.; Gaur, T.; Lengner, C.J.; Young, D.W. Networks and hubs for the transcriptional control of osteoblastogenesis. Rev. Endocr. Metab. Disord. 2006, 7, 1-16.
20. Nakashima, K.; Zhou, X.; Kunkel, G.; Zhang, Z.; Deng, J.M.; Behringer, R.R.; de Crombrugghe, B. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002, 108, 17-29.
21. Zhu, F.; Friedman, M.S.; Luo, W.; Woolf, P.; Hankenson, K.D. The transcription factor osterix (sp7) regulates BMP6-induced human osteoblast differentiation. J. Cell. Physiol. 2012, 227, 2677-2685.
22. Westendorf, J.J.; Kahler, R.A.; Schroeder, T.M. Wnt signaling in osteoblasts and bone diseases. Gene 2004, 341, 19-39.
23. Hens, J.R.; Wilson, K.M.; Dann, P.; Chen, X.; Horowitz, M.C.; Wysolmerski, J.J. Topgal mice show that the canonical wnt signaling pathway is active during bone development and growth and is activated by mechanical loading in vitro. J. Bone Miner. Res. 2005, 20, 1103-1113.
24. Hill, T.P.; Spater, D.; Taketo, M.M.; Birchmeier, W.; Hartmann, C. Canonical wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Devel. Cell 2005, 8, 727-738.
25. Bodine, P.V.; Komm, B.S. Wnt signaling and osteoblastogenesis. Rev. Endocr. Metab. Disord. 2006, 7, 33-39.
26. Murshed, M.; Harmey, D.; Millan, J.L.; McKee, M.D.; Karsenty, G. Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ecm mineralization to bone. Genes Dev. 2005, 19, 1093-1104.
27. Bonewald, L. Osteocytes as multifunctional cells. J. Musculoskelet. Neuronal Interact. 2006, 6, 331-333.
28. Udagawa, N.; Takahashi, N.; Yasuda, H.; Mizuno, A.; Itoh, K.; Ueno, Y.; Shinki, T.; Gillespie, M.T.; Martin, T.J.; Higashio, K.; et al. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. Endocrinology 2000, 141, 3478-3484.
29. Zhao, C.; Irie, N.; Takada, Y.; Shimoda, K.; Miyamoto, T.; Nishiwaki, T.; Suda, T.; Matsuo, K. Bidirectional ephrinb2-ephb4 signaling controls bone homeostasis. Cell Met. 2006, 4, 111-121.
30. Eriksen, E.F. Cellular mechanisms of bone remodeling. Rev. Endocr. Metab. Disord. 2010, 11, 219-227.
31. Kratchmarova, I.; Blagoev, B.; Haack-Sorensen, M.; Kassem, M.; Mann, M. Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation. Science 2005, 308, 1472-1477.
32. Haussler, M.R.; Whitfield, G.K.; Kaneko, I.; Forster, R.; Saini, R.; Hsieh, J.C.; Haussler, C.A.; Jurutka, P.W. The role of vitamin D in the fgf23, klotho, and phosphate bone-kidney endocrine axis. Rev. Endocr. Metab. Disord. 2012, 13, 57-69.
33. Ambros, V. Micrornas: Tiny regulators with great potential. Cell 2001, 107, 823-826.
34. Hruska, K.A. Vascular smooth muscle cells in the pathogenesis of vascular calcification. Circ. Res. 2009, 104, 710-711.
35. Goettsch, C.; Rauner, M.; Pacyna, N.; Hempel, U.; Bornstein, S.R.; Hofbauer, L.C. Mir-125b regulates calcification of vascular smooth muscle cells. Am. J. Pathol. 2011, 179, 1594-1600.
36. Qiao, W.; Chen, L.; Zhang, M. Microrna-205 regulates the calcification and osteoblastic differentiation of vascular smooth muscle cells. Cell. Physiol. Biochem. 2014, 33, 1945-1953.
37. Liao, X.B.; Zhang, Z.Y.; Yuan, K.; Liu, Y.; Feng, X.; Cui, R.R.; Hu, Y.R.; Yuan, Z.S.; Gu, L.; Li, S.J.; et al. Mir-133a modulates osteogenic differentiation of vascular smooth muscle cells. Endocrinology 2013, 154, 3344-3352.
38. Cui, R.R.; Li, S.J.; Liu, L.J.; Yi, L.; Liang, Q.H.; Zhu, X.; Liu, G.Y.; Liu, Y.; Wu, S.S.; Liao, X.B.; et al. Microrna-204 regulates vascular smooth muscle cell calcification in vitro and in vivo. Cardiovasc. Res. 2012, 96, 320-329.
39. Dhore, C.R.; Cleutjens, J.P.; Lutgens, E.; Cleutjens, K.B.; Geusens, P.P.; Kitslaar, P.J.; Tordoir, J.H.; Spronk, H.M.; Vermeer, C.; Daemen, M.J. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler. Thromb. Vasc. Biol. 2001, 21, 1998-2003.
40. Balderman, J.A.; Lee, H.Y.; Mahoney, C.E.; Handy, D.E.; White, K.; Annis, S.; Lebeche, D.; Hajjar, R.J.; Loscalzo, J.; Leopold, J.A. Bone morphogenetic protein-2 decreases microrna-30b and microrna-30c to promote vascular smooth muscle cell calcification. JAHA 2012, 1, doi:10.1161/JAHA.112.003905.
41. Nigam, V.; Sievers, H.H.; Jensen, B.C.; Sier, H.A.; Simpson, P.C.; Srivastava, D.; Mohamed, S.A. Altered micrornas in bicuspid aortic valve: A comparison between stenotic and insufficient valves. J. Heart Valve Dis. 2010, 19, 459-465.
42. Li, Z.; Hassan, M.Q.; Volinia, S.; van Wijnen, A.J.; Stein, J.L.; Croce, C.M.; Lian, J.B.; Stein, G.S. A microrna signature for a BMP2-induced osteoblast lineage commitment program. PNAS 2008, 105, 13906-13911.
43. Kapinas, K.; Kessler, C.; Ricks, T.; Gronowicz, G.; Delany, A.M. Mir-29 modulates wnt signaling in human osteoblasts through a positive feedback loop. J. Biol. Chem. 2010, 285, 25221-25231.
44. Kapinas, K.; Kessler, C.B.; Delany, A.M. Mir-29 suppression of osteonectin in osteoblasts: Regulation during differentiation and by canonical wnt signaling. J. Cell. Biochem. 2009, 108, 216-224.
45. Du, Y.; Gao, C.; Liu, Z.; Wang, L.; Liu, B.; He, F.; Zhang, T.; Wang, Y.; Wang, X.; Xu, M.; et al. Upregulation of a disintegrin and metalloproteinase with thrombospondin motifs-7 by mir-29 repression mediates vascular smooth muscle calcification. Arterioscler. Thromb. Vasc. Biol. 2012, 32, 2580-2588.
46. Boon, R.A.; Seeger, T.; Heydt, S.; Fischer, A.; Hergenreider, E.; Horrevoets, A.J.; Vinciguerra, M.; Rosenthal, N.; Sciacca, S.; Pilato, M.; et al. Microrna-29 in aortic dilation: Implications for aneurysm formation. Circ. Res. 2011, 109, 1115-1119.
47. Lim, K.; Lu, T.S.; Molostvov, G.; Lee, C.; Lam, F.T.; Zehnder, D.; Hsiao, L.L. Vascular klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23. Circulation 2012, 125, 2243-2255.
48. Gui, T.; Zhou, G.; Sun, Y.; Shimokado, A.; Itoh, S.; Oikawa, K.; Muragaki, Y. Micrornas that target Ca(2+) transporters are involved in vascular smooth muscle cell calcification. Lab. Invest. 2012, 92, 1250-1259.
49. Rangrez, A.Y.; Massy, Z.A.; Metzinger-Le Meuth, V.; Metzinger, L. Mir-143 and mir-145: Molecular keys to switch the phenotype of vascular smooth muscle cells. Circ. Cardiovasc. Genet. 2011, 4, 197-205.
50. Taibi, F.; Metzinger-Le Meuth, V.; Massy, Z.A.; Metzinger, L. Mir-223: An inflammatory oncomir enters the cardiovascular field. Biochim. Biophys. Acta 2014, 1842, 1001-1009.
51. Taibi, F.; Metzinger-le Meuth, V.; M’Baya-Moutoula, E.; Djelouat, M.; Louvet, L.; Bugnicourt, J.M.; Poirot, S.; Bengrine, A.; Chillon, J.M.; Massy, Z.A.; et al. Possible involvement of micrornas in vascular damage in experimental chronic kidney disease. Biochim. Biophys. Acta 2014, 1842, 88-98.
52. Mackenzie, N.C.; Staines, K.A.; Zhu, D.; Genever, P.; Macrae, V.E. Mirna-221 and mirna-222 synergistically function to promote vascular calcification. Cell. Biochem. Func. 2014, 32, 209-216.
53. Clement, T.; Salone, V.; Charpentier, B.; Jouzeau, J.Y.; Bianchi, A. Identification of new micrornas targeting genes regulating the pi/ppi balance in chondrocytes. Biomed. Mat. Eng. 2014, 24, 3-16.
54. Davis-Dusenbery, B.N.; Wu, C.; Hata, A. Micromanaging vascular smooth muscle cell differentiation and phenotypic modulation. Arterioscler. Thromb. Vasc. Biol. 2011, 31, 2370-2377.
55. Liu, X.; Cheng, Y.; Yang, J.; Qin, S.; Chen, X.; Tang, X.; Zhou, X.; Krall, T.J.; Zhang, C. Flank sequences of mir-145/143 and their aberrant expression in vascular disease: Mechanism and therapeutic application. JAHA 2013, 2, doi:10.1161/JAHA.113.000407.
56. Davis-Dusenbery, B.N.; Chan, M.C.; Reno, K.E.; Weisman, A.S.; Layne, M.D.; Lagna, G.; Hata, A. Down-regulation of kruppel-like factor-4 (klf4) by microrna-143/145 is critical for modulation of vascular smooth muscle cell phenotype by transforming growth factor-beta and bone morphogenetic protein 4. J. Biol. Chem. 2011, 286, 28097-28110.
57. Chen, C.; Cheng, P.; Xie, H.; Zhou, H.D.; Wu, X.P.; Liao, E.Y.; Luo, X.H. Mir-503 regulates osteoclastogenesis via targeting rank. J. Bone Miner. Res. 2014, 29, 338-347.
58. Cordes, K.R.; Sheehy, N.T.; White, M.P.; Berry, E.C.; Morton, S.U.; Muth, A.N.; Lee, T.H.; Miano, J.M.; Ivey, K.N.; Srivastava, D. Mir-145 and mir-143 regulate smooth muscle cell fate and plasticity. Nature 2009, 460, 705-710.
59. Fiedler, J.; Stohr, A.; Gupta, S.K.; Hartmann, D.; Holzmann, A.; Just, A.; Hansen, A.; Hilfiker-Kleiner, D.; Eschenhagen, T.; Thum, T. Functional microrna library screening identifies the hypoxamir mir-24 as a potent regulator of smooth muscle cell proliferation and vascularization. Antioxid. Redox Signal. 2014, 21, 1167-1176.
60. Kapustin, A.N.; Shanahan, C.M. Calcium regulation of vascular smooth muscle cell-derived matrix vesicles. Trends Cardiovasc. Med. 2012, 22, 133-137.
61. Kapustin, A.N.; Davies, J.D.; Reynolds, J.L.; McNair, R.; Jones, G.T.; Sidibe, A.; Schurgers, L.J.; Skepper, J.N.; Proudfoot, D.; Mayr, M.; et al. Calcium regulates key components of vascular smooth muscle cell-derived matrix vesicles to enhance mineralization. Circ. Res. 2011, 109, e1-e12.
62. Chen, N.X.; O'Neill, K.; Chen, X.; Kiattisunthorn, K.; Gattone, V.H.; Moe, S.M. Transglutaminase 2 accelerates vascular calcification in chronic kidney disease. Am. J. Nephrol 2013, 37, 191-198.
63. Villarroya-Beltri, C.; Gutierrez-Vazquez, C.; Sanchez-Cabo, F.; Perez-Hernandez, D.; Vazquez, J.; Martin-Cofreces, N.; Martinez-Herrera, D.J.; Pascual-Montano, A.; Mittelbrunn, M.; Sanchez-Madrid, F. Sumoylated hnrnpa2b1 controls the sorting of mirnas into exosomes through binding to specific motifs. Nat. Commun. 2013, 4, 2980.
64. Eirin, A.; Riester, S.M.; Zhu, X.Y.; Tang, H.; Evans, J.M.; O'Brien, D.; van Wijnen, A.J.; Lerman, L.O. Microrna and mrna cargo of extracellular vesicles from porcine adipose tissue-derived mesenchymal stem cells. Gene 2014, doi:10.1016/j.gene.2014.08.041.
65. Nair, R.; Santos, L.; Awasthi, S.; von Erlach, T.; Chow, L.W.; Bertazzo, S.; Stevens, M.M. Extracellular vesicles derived from preosteoblasts influence embryonic stem cell differentiation. Stem Cells Dev. 2014, 23, 1625-1635.
66. Guduric-Fuchs, J.; O'Connor, A.; Camp, B.; O’Neill, C.L.; Medina, R.J.; Simpson, D.A. Selective extracellular vesicle-mediated export of an overlapping set of micrornas from multiple cell types. BMC Genomics 2012, 13, doi:10.1186/1471-2164-13-357.
67. Arroyo, J.D.; Chevillet, J.R.; Kroh, E.M.; Ruf, I.K.; Pritchard, C.C.; Gibson, D.F.; Mitchell, P.S.; Bennett, C.F.; Pogosova-Agadjanyan, E.L.; Stirewalt, D.L.; et al. Argonaute2 complexes carry a population of circulating micrornas independent of vesicles in human plasma. PNAS 2011, 108, 5003-5008.
68. Hergenreider, E.; Heydt, S.; Treguer, K.; Boettger, T.; Horrevoets, A.J.; Zeiher, A.M.; Scheffer, M.P.; Frangakis, A.S.; Yin, X.; Mayr, M.; et al. Atheroprotective communication between endothelial cells and smooth muscle cells through mirnas. Nat. Cell. Biol. 2012, 14, 249-256.
69. Zhou, J.; Li, Y.S.; Nguyen, P.; Wang, K.C.; Weiss, A.; Kuo, Y.C.; Chiu, J.J.; Shyy, J.Y.; Chien, S. Regulation of vascular smooth muscle cell turnover by endothelial cell-secreted microrna-126: Role of shear stress. Circ. Res. 2013, 113, 40-51.
70. Chen, N.X.; Kiattisunthorn, K.; O'Neill, K.D.; Chen, X.; Moorthi, R.N.; Gattone, V.H.; Allen, M.R.; Moe, S.M. Decreased microrna is involved in the vascular remodeling abnormalities in chronic kidney disease (CKD). PloS One 2013, 8, doi:10.1371/journal.pone.0064558.
71. Wang, H.; Peng, W.; Ouyang, X.; Dai, Y. Reduced circulating mir-15b is correlated with phosphate metabolism in patients with end-stage renal disease on maintenance hemodialysis. Ren. Fail. 2012, 34, 685-690.
72. Goettsch, C.; Hutcheson, J.D.; Aikawa, E. Microrna in cardiovascular calcification: Focus on targets and extracellular vesicle delivery mechanisms. Circ. Res. 2013, 112, 1073-1084.
73. Otto, F.; Thornell, A.P.; Crompton, T.; Denzel, A.; Gilmour, K.C.; Rosewell, I.R.; Stamp, G.W.; Beddington, R.S.; Mundlos, S.; Olsen, B.R.; et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997, 89, 765-771.
74. Enomoto, H.; Shiojiri, S.; Hoshi, K.; Furuichi, T.; Fukuyama, R.; Yoshida, C.A.; Kanatani, N.; Nakamura, R.; Mizuno, A.; Zanma, A.; et al. Induction of osteoclast differentiation by runx2 through receptor activator of nuclear factor-kappa b ligand (rankl) and osteoprotegerin regulation and partial rescue of osteoclastogenesis in runx2-/- mice by rankl transgene. J. Biol. Chem. 2003, 278, 23971-23977.
75. Byon, C.H.; Sun, Y.; Chen, J.; Yuan, K.; Mao, X.; Heath, J.M.; Anderson, P.G.; Tintut, Y.; Demer, L.L.; Wang, D.; et al. Runx2-upregulated receptor activator of nuclear factor kappab ligand in calcifying smooth muscle cells promotes migration and osteoclastic differentiation of macrophages. Arterioscler. Thromb. Vasc. Biol. 2011, 31, 1387-1396.
76. Sun, Y.; Byon, C.H.; Yuan, K.; Chen, J.; Mao, X.; Heath, J.M.; Javed, A.; Zhang, K.; Anderson, P.G.; Chen, Y. Smooth muscle cell-specific runx2 deficiency inhibits vascular calcification. Circ. Res. 2012, 111, 543-552.
77. Sugatani, T.; Hruska, K.A. Impaired micro-rna pathways diminish osteoclast differentiation and function. J. Biol. Chem. 2009, 284, 4667-4678.
78. Sugatani, T.; Hildreth, B.E.; Toribio, R.E.; Malluche, H.H.; Hruska, K.A. Expression of dgcr8-dependent micrornas is indispensable for osteoclastic development and bone-resorbing activity. J. Cell. Biochem. 2014, 115, 1043-1047.
79. Sun, X.; Zhang, M.; Sanagawa, A.; Mori, C.; Ito, S.; Iwaki, S.; Satoh, H.; Fujii, S. Circulating microrna-126 in patients with coronary artery disease: Correlation with ldl cholesterol. Thromb. J. 2012, 10, 16.
80. Meng, S.; Cao, J.T.; Zhang, B.; Zhou, Q.; Shen, C.X.; Wang, C.Q. Downregulation of microrna-126 in endothelial progenitor cells from diabetes patients, impairs their functional properties, via target gene spred-1. J. Mol. Cell. Cardiol. 2012, 53, 64-72.
81. Nakasa, T.; Shibuya, H.; Nagata, Y.; Niimoto, T.; Ochi, M. The inhibitory effect of microrna-146a expression on bone destruction in collagen-induced arthritis. Arthritis Rheum. 2011, 63, 1582-1590.
82. Chen, T.; Li, Z.; Jing, T.; Zhu, W.; Ge, J.; Zheng, X.; Pan, X.; Yan, H.; Zhu, J. Microrna-146a regulates the maturation process and pro-inflammatory cytokine secretion by targeting cd40l in oxldl-stimulated dendritic cells. FEBS Lett. 2011, 585, 567-573.
83. Krzeszinski, J.Y.; Wei, W.; Huynh, H.; Jin, Z.; Wang, X.; Chang, T.C.; Xie, X.J.; He, L.; Mangala, L.S.; Lopez-Berestein, G.; et al. Mir-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and tgif2. Nature 2014, 512, 431-435.
84. Rossi, M.; Pitari, M.R.; Amodio, N.; Di Martino, M.T.; Conforti, F.; Leone, E.; Botta, C.; Paolino, F.M.; del Giudice, T.; Iuliano, E.; et al. Mir-29b negatively regulates human osteoclastic cell differentiation and function: Implications for the treatment of multiple myeloma-related bone disease. J. Cell. Physiol. 2013, 228, 1506-1515.
85. Franceschetti, T.; Kessler, C.B.; Lee, S.K.; Delany, A.M. Mir-29 promotes murine osteoclastogenesis by regulating osteoclast commitment and migration. J. Biol. Chem. 2013, 288, 33347-33360.
86. Cheng, P.; Chen, C.; He, H.B.; Hu, R.; Zhou, H.D.; Xie, H.; Zhu, W.; Dai, R.C.; Wu, X.P.; Liao, E.Y.; et al. Mir-148a regulates osteoclastogenesis by targeting v-maf musculoaponeurotic fibrosarcoma oncogene homolog b. J. Bone Miner. Res. 2013, 28, 1180-1190.
87. Guo, L.J.; Liao, L.; Yang, L.; Li, Y.; Jiang, T.J. Mir-125a tnf receptor-associated factor 6 to inhibit osteoclastogenesis. Exp. Cell Res. 2014, 321, 142-152.